Daniel P. Van Plew - 06 Dec 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP & General Mgr, Industrial
Signature
/s/ Daniel P. Van Plew
Issuer symbol
REGN
Transactions as of
06 Dec 2024
Transactions value $
-$387,204
Form type
4
Filing time
10 Dec 2024, 16:03:18 UTC
Previous filing
16 Feb 2024
Next filing
18 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Award $0 +3,499 +11% $0 36,253 06 Dec 2024 Direct F1
transaction REGN Common Stock Tax liability -$387,204 -492 -1.4% $787 35,761 09 Dec 2024 Direct
holding REGN Common Stock 1,100 06 Dec 2024 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Award $0 +13,472 $0 13,472 06 Dec 2024 Common Stock 13,472 $771.64 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 6, 2026 and 50% on December 6, 2028.
F2 The stock option award vests in four equal annual installments, commencing one year after the date of grant.